or Try an Advanced Search...

    Technical Analysis for CELU - Celularity Inc.

    Grade Last Price % Change Price Change
    C 2.94 0.68% 0.02
    CELU closed up 0.68 percent on Wednesday, November 20, 2024, on 9 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical CELU trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Calm After Storm Range Contraction 0.68%
    NR7 Range Contraction 0.68%
    Narrow Range Bar Range Contraction 0.68%
    Older End-of-Day Signals for CELU ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    Rose Above Previous Day's High about 21 hours ago
    Down 3% about 22 hours ago
    Down 2 % about 22 hours ago
    Down 1% about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CELU Chart by TradingView
    Basic chart:

    Profile

    Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Biotechnology Cancer Biology Immune System Stem Cell Cell Therapy Natural Killer Cell Lymphocytes Therapeutic Solutions

    Is CELU a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
    Nov 18 Celularity announces resolution of Nasdaq listing compliance matter
    Nov 18 Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
    Nov 7 Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
    Oct 23 Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel
    Oct 22 Celularity Provides Corporate Update
    Oct 21 Celularity receives Nasdaq notice, intends to file appeal
    Oct 18 Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
    Oct 16 Celularity acquires Rebound product from Sequence Lifescience
    Oct 16 Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.
    See more CELU news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.97
    52 Week Low 1.3
    Average Volume 1,284,240
    200-Day Moving Average 3.35
    50-Day Moving Average 2.55
    20-Day Moving Average 2.36
    10-Day Moving Average 3.08
    Average True Range 0.67
    RSI (14) 54.95
    ADX 37.72
    +DI 26.91
    -DI 13.85
    Chandelier Exit (Long, 3 ATRs) 3.21
    Chandelier Exit (Short, 3 ATRs) 3.31
    Upper Bollinger Bands 3.98
    Lower Bollinger Band 0.73
    Percent B (%b) 0.68
    BandWidth 137.79
    MACD Line 0.16
    MACD Signal Line 0.09
    MACD Histogram 0.0686
    Fundamentals Value
    Market Cap 636.23 Million
    Num Shares 216 Million
    EPS -1.03
    Price-to-Earnings (P/E) Ratio -2.85
    Price-to-Sales 6.26
    Price-to-Book 2.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.38
    Resistance 3 (R3) 3.37 3.21 3.30
    Resistance 2 (R2) 3.21 3.10 3.22 3.28
    Resistance 1 (R1) 3.08 3.03 3.15 3.09 3.25
    Pivot Point 2.92 2.92 2.96 2.93 2.92
    Support 1 (S1) 2.79 2.81 2.86 2.80 2.63
    Support 2 (S2) 2.63 2.74 2.64 2.60
    Support 3 (S3) 2.50 2.63 2.58
    Support 4 (S4) 2.51